Therapeutic Potential of Vortioxetine for Anhedonia-Like Symptoms in Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan.

Koichiro Watanabe Shinji FujimotoTatsuro MarumotoTadayuki KitagawaKazuyuki IshidaTadashi NakajimaYoshiya MoriguchiKeita FujikawaTakeshi Inoue

Published in: Neuropsychiatric disease and treatment (2022)

This post hoc analysis suggests that vortioxetine may have therapeutic potential in patients with anhedonia-like symptoms of major depressive disorder. ClinicalTrials.gov identifier for primary study: NCT02389816.

Keyphrases

major depressive disorder
bipolar disorder
clinical trial
sleep quality
depressive symptoms
big data
phase ii
study protocol
physical activity
double blind
phase iii